ARTICLE | Company News
Japan approves Bayer's riociguat for CTEPH
January 18, 2014 2:17 AM UTC
Bayer AG (Xetra:BAYN) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Adempas riociguat to treat inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CT...